PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

ABSTRACT:

SUBMITTER: Munshi N 

PROVIDER: S-EPMC9429434 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature